Filippatos TD, Elisaf MS. Combination drug treatment in patients with non-alcoholic fatty liver disease. World J Hepatol 2010; 2(4): 139-142 [PMID: 21160985 DOI: 10.4254/wjh.v2.i4.139]
Corresponding Author of This Article
Moses S Elisaf, MD, FRSH, FASA, FISA, Professor of Medicine, Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina 45110, Greece. egepi@cc.uoi.gr
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/